跳至主要内容
临床试验/NCT06926946
NCT06926946尚未招募不适用

The Effects of Treatment Guided by Cerebral Oximetry Monitoring on Renal Outcomes in Invasively Mechanically Ventilated Neonates: an Ancillary Study of the SafeBoosC-IIIv Trial

St. John's Research Institute2 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2025年7月31日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,000
试验地点
2
主要终点
composite outcome of death and acute kidney injury

研究概览

简要总结

Cerebral oximetry monitoring allows clinicians to optimize blood flow to the brain and oxygenation using the SafeBoosC treatment guideline. The guideline's interventions aims to stabilize blood pressure and oxygen levels.

As low blood pressure is a risk factor for the development of kidney injury, normalizing blood pressure may decrease the incidence of kidney injury in new-borns who are on ventilator.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
1 Day 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • > 28 weeks of gestation Invasively ventilated

排除标准

  • major anomalies

结局指标

主要结局

composite outcome of death and acute kidney injury

时间窗: From randomization to discharge up to 2months of life

composite outcome of death and acute kidney injury

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验